
Sign up to save your podcasts
Or


On this week’s Tech Nation, Moira speaks with Henry Abbott, former ESPN journalist and author of "Ballistic: The New Science of Injury-Free Athletic Performance". Then, Dr. Lorin Johnson, CSO of Glycyx Therapeutics, explains why opioids prescribed for cancer pain may be limiting the effectiveness of immunotherapy, and how their upcoming clinical trials hope to fix it.
By Tech Nation4.4
6060 ratings
On this week’s Tech Nation, Moira speaks with Henry Abbott, former ESPN journalist and author of "Ballistic: The New Science of Injury-Free Athletic Performance". Then, Dr. Lorin Johnson, CSO of Glycyx Therapeutics, explains why opioids prescribed for cancer pain may be limiting the effectiveness of immunotherapy, and how their upcoming clinical trials hope to fix it.

22,024 Listeners

43,971 Listeners

32,156 Listeners

38,515 Listeners

6,744 Listeners

43,778 Listeners

27,206 Listeners

2,866 Listeners

9,177 Listeners

465 Listeners

723 Listeners

924 Listeners

6,352 Listeners

931 Listeners

32 Listeners